Courses

New and emerging treatments in psychiatry

Course information

Level

Introductory

Locations

This course will be taking place online

Book-now

Course information

Level

Introductory

Locations

This course will be taking place online

Share this page

About the course

From psychedelics to gut microbiome, this two-day course will introduce clinicians to the major new interventions in psychiatry with strong or promising clinical evidence.

Drawing on recent exciting research findings, many of these interventions shine a new light on the causes and pathologies associated with psychiatric illnesses and are paving the way towards the future of psychiatry.

As our understanding of the causes of mental illness has developed, a growing number of pharmacological and non-pharmacological interventions have shown potential as novel treatments. While some of these remain experimental, others are emerging into routine clinical practice in the UK and around the world. This course will cover topics such as psilocybin, ketamine, MDMA, cannabis, transcranial magnetic stimulation, triple chronotherapy, and gut microbiome.

Learners will become familiar with the sorts of treatments currently available through either clinical or research pathways and be able to recommend these to their patients where appropriate. Each session will be taught by well-known academic and clinical experts from the IoPPN/Maudsley who work at the frontier of mental health research including Prof. Allan Young (KCL Chair of Mood Disorders) and Prof. David Veale (Director of the Maudsley national service for OCD and related disorders).

An interview with Dr James Rucker - https://youtu.be/2VsUw9irJ0k

Course Programme

Day 1 schedule

9:00-9:30 Arrival, tea, coffee and biscuits
9:30-10:00 Overview
10:00-10:45 The Transcranial Magnetic Stimulation clinic at Oxleas NHS Trust. Experience of delivery and mechanisms.
10:45-11:30 Transcranial Magnetic Stimulation for Functional Neurological Disorders. Mechanisms and Clinic Utility.
11:30-11:45 Coffee Break
11:45-12:30 Triple chronotherapy for resistant depression.
12:30-13:00 Panel and audience discussion: TMS and triple chronotherapy.
13:00-14:00 Lunch
14:00-14:45 Cannabis prescribing in the UK: experience from the first CQC-approved clinic in the UK
14:45-15:30 Influencing the microbiome to treat psychiatric disorders
15:30-16:15 MDMA for Post-Traumatic Stress Disorder – an overview of current clinical trials
16:15-16:45 Panel and audience discussion: Cannabis, the microbiome and MDMA for PTSD
16:45 Close

Day 2 schedule

9:00-9:30 Arrival, tea, coffee and biscuits
9:30-10:15 Classical psychedelics in the treatment of psychiatric disorders: an introduction
10:15-11:00 Psilocybin trials at King’s College London
11:00-11:30 Coffee Break
11:30-12:15 Therapeutic models of psychological support in psilocybin therapy.
12:15-13:00 Panel and audience discussion: psilocybin therapy
13:00-14:00 Lunch
14:00-14:45 Clinical use of ketamine in mood disorders
14:45-15:30 Ketamine therapy at the Maudsley Advanced Treatment Service (MATS).
15:30-16:00 Panel and audience discussion: ketamine therapy in psychiatry
16:00 Closing comments

Learning objectives

Describe a variety of emerging novel pharmacological and non-pharmacological treatments in psychiatry	Identify scientific and clinical evidence base supporting the major emerging treatments in psychiatry
Determine whether some novel treatments may be appropriate for their patients	Signpost patients to service or research programs that provide novel treatments

Course presented by

Dr Derek K. Tracy

The Medical Director of West London NHS Trust

Derek is the Medical Director of West London NHS Trust, and a senior lecturer at King's College London and University College London.

Professor Allan Young

Chair of Mood Disorders & Director of the Centre for Affective Disorders

Prof Young holds the Chair of Mood Disorders at King’s College London where he is also Director of the Centre for Affective Disorders.

Dr James Rucker

Consultant Psychiatrist and Senior Clinical Lecturer

James Rucker is a Consultant Psychiatrist and a Senior Clinical Lecturer in mood disorders and psychopharmacology at the Centre for Affective Disorders at the Institute of Psychiatry...

Dr Mario F Juruena

Clinical Senior Lecturer in Translational Psychiatry & Maudsley Advanced Treatment

Clinical Senior Lecturer in Translational Psychiatry & Maudsley Advanced Treatment and ECT Service Consultant Lead - MATS

Dr Rafael Euba

Repetitive transcranial magnetic stimulation

At: Oxleas NHS Foundation Trust

Course schedule

Target audience

Academic, Assistant psychologist, Clinical psychologist, Consultant – psychiatry, CT1-3 – psychiatry, GP, Occupational therapist, Psychology student, Psychotherapist, RMN, ST4-7 – psychiatry

Select the type of ticket you would like to purchase

Commission options

Group bookings

Bespoke courses

We are able to offer custom-made programs, whether digital or face to face, to meet the education and training needs of your organisation in the UK or internationally. We would welcome the opportunity to discuss your requirements and develop a proposal.

Research

Let our team complete a full Training Needs Analysis for a department, directorate, or the whole hospital! We can work to complete this ourselves or work collaboratively with your own staff. Our standard outcome measures assess learner progress and produce a full report looking at wider impact of training using a range of tested assessment methodologies.

New and emerging treatments in psychiatry

Course presented by

Course schedule

Group bookings

Bespoke courses

Research

Latest news, podcasts and blogs

NHS England and Maudsley Learning collaborate to enhance mental health education for physician associates

Stress in University Students: Empowering Students to Take Control

Interview #47: When Anxiety gets Severe (with Lisa Williams at the Anxiety Disorders Residential Unit)